Yayınlar & Eserler

Yayın Ağı
Makaleler 20
Tümü (20)
SCI-E, SSCI, AHCI (18)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (1)
Scopus (19)
TRDizin (4)

1. Fibrosis-4 Score and Postoperative Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease

EREN F., GÖKTUĞ M. R., Ari D., Ozkumur G. F., Bulbuller E. N., Gencdal G., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.37, sa.1, 2026 (SCI-Expanded, Scopus, TRDizin) identifier identifier

2. Prevalence and Clinical Associations of Malnutrition and Sarcopenia Risk in Gastroenterology Inpatients: A Multicenter Cross-Sectional Study in Turkey

BENGİ G., DOLU S., Ozden Y., Oruc N., Tozlu M., Hakim G. D., et al.
DIAGNOSTICS , cilt.15, sa.22, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Usefulness of Endoscopic Ultrasound Strain Elastography for Measuring Liver Stiffness and the Role of Blood Cytokeratin 18 Levels as a Surrogate Marker of Fibrosis

Duman D. G., Alahdab Y. O., DEMİRTAŞ C. Ö., YILMAZ Y., Dilber F., Ozdemir F. T., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.36, sa.10, 2025 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

4. Pruritus and Fatigue in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study of Turkish Patients From the Global NASH/MASH Registry

YILMAZ Y., Keklikkiran Ç., Racila A., Stepanova M., Younossi Z.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY , cilt.16, sa.6, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

5. Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1

Karatas F. N., Keklikkıran Ç., Yılmaz Y., Ay N. P., Korten V., Sili U.
CURRENT HIV RESEARCH , cilt.23, sa.2, ss.121-132, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study

Ergenc I., Kara E., Yilmaz M. E., DEMİRTAŞ C. Ö., Keklikkiran Ç., Das T., et al.
HELIYON , cilt.10, sa.14, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

Younossi Z. M., AlQahtani S. A., Funuyet-Salas J., Romero-Gómez M., YILMAZ Y., Keklikkiran Ç., et al.
JHEP REPORTS , cilt.6, sa.7, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. Diagnostic accuracy of AGILE 3+score for advanced fibrosis in patients with NAFLD: A systematic review and meta-analysis

Dalbeni A., Lombardi R., Henrique M., Zoncape M., Pennisi G., Petta S., et al.
HEPATOLOGY , cilt.79, sa.5, ss.1107-1116, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

9. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

Younossi Z. M., Alqahtani S. A., Alswat K., YILMAZ Y., Keklikkiran Ç., Funuyet-Salas J., et al.
JOURNAL OF HEPATOLOGY , cilt.80, sa.3, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

10. Can Frequent Toothbrushing Reduce the Risk of Cirrhosis among Patients with Non-alcoholic Fatty Liver Disease? Hints from a Registry-based Study

Keklikkiran Ç., Stepanova M., Younossi Z., Yilmaz Y.
DIGESTIVE DISEASES , cilt.41, sa.6, ss.932-937, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients

ERGENÇ İ., Gozaydinoglu B., KEKLİKKİRAN Ç., YILMAZ Y.
Hepatology forum , cilt.4, sa.2, ss.69-73, 2023 (TRDizin) Creative Commons License identifier identifier identifier

12. Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study

Yilmaz Y., Toraman A. E., Alp C., Doğan Z., Keklikkiran Ç., Stepanova M., et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.57, sa.2, ss.215-223, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

13. Global multi-stakeholder endorsement of the MAFLD definition

Méndez-Sánchez N., Bugianesi E., Gish R. G., Lammert F., Tilg H., Nguyen M. H., et al.
The Lancet Gastroenterology and Hepatology , cilt.7, sa.5, ss.388-390, 2022 (SCI-Expanded, Scopus) identifier identifier identifier identifier

14. Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study

Demirtas C. O., Keklikkiran Ç., Ergenc I., Erturk Sengel B., Eskidemir G., Cinel I., et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Causes of erectile dysfunction in non-alcoholic fatty liver disease

KANİ H. T., ŞENER T. E., Aykut U. E., DEMİRTAŞ C. Ö., Keklikkiran Ç., Ergenc I., et al.
HEPATOLOGY FORUM , cilt.2, sa.2, ss.60-63, 2021 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Recommendations for Reopening Endoscopy Units in Turkey: A Set-up Plan from a Tertiary Center in Istanbul.

Demirtas C. Ö., Keklikkıran Ç., Mehdiyev S., Ergenç İ., Özen Alahdab Y., Gündüz F., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.32, ss.113-115, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier identifier

17. Evaluation of the Association between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study

Demirci A. F., Demirtas C. O., Eren F., Yilmaz D., Keklikkiran Ç., Ozdogan O. C., et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , cilt.29, sa.4, ss.617-622, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

18. External validation of the Toronto hepatocellular carcinoma risk index in Turkish cirrhotic patients

Demirtas C., Gunduz F., Kani H., Keklikkıran Ç., Alahdab Y., Yılmaz Y., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.32, sa.7, ss.882-888, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

19. Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease.

Kaya E., Bakir A., Kani H., Demirtas C., Keklikkiran Ç., Yilmaz Y.
Gut and liver , cilt.14, ss.486-491, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

20. Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease: a transient elastography study.

Bilgin B., Sunbul M., Kani H. T., Demirtas C., Keklikkiran Ç., Yilmaz Y.
European journal of gastroenterology & hepatology , cilt.32, ss.54-57, 2020 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. Obstrüktif Uyku Apne Sendromlu Hastalarda Non-Alkolik Yağlı Karaciğer Hastalığının Değerlendirilmesi

Özyurt S., Keklikkıran Ç., Yılmaz Kara B., Özçelik N., Gümüş A., Şahin Ü., et al.
UASK 2025, Antalya, Türkiye, 9 - 12 Nisan 2025, (Özet Bildiri)

2. Pruritus and fatigue in patients with metabolic dysfunction associated steatotic liver disease (MASLD):Data from the Global NASH/MASH Registry

Yılmaz Y., Keklikkıran Ç., Racila A., Stepanova M., Younossi Z.
APASL Congress 2025, Beijing, Çin, 26 - 31 Mart 2025, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

3. THE IMPACT OF SUPERIMPOSED METABOLICDYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD) ON CLINICAL AND PATIENT- REPORTED OUTCOMES ( PROS) PROFILE OF PATIENTS WITH CHRONIC HEPATITIS B ( CHB) AND C ( CHC)

Younossi Z., Buti M., Papatheodoridis G., YILMAZ Y., Yu M., El-Kassas M., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, cilt.80, (Özet Bildiri) identifier

4. PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) HAVE SIMILAR CLINICAL, NON-INVASIVE TESTS ( NITS) AND PATIENT-REPORTED OUTCOMES (PROS) PROFILE

Younossi Z., YILMAZ Y., Yu L., Isakov V., Fernandez M. I. C., Wong V., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, cilt.80, (Özet Bildiri) identifier

5. FATIGUE IN CHRONIC HEPATITIS B (CHB) AND C (CHC) IS ASSOCIATED WITH IMPAIRMENT OF PATIENT-REPORTED OUTCOMES (PROS) AND WORK PRODUCTIVITY

YILMAZ Y., Yu M., Alswat K., El-Kassas M., Buti M., Papatheodoridis G., et al.
The Liver Meeting, California, Amerika Birleşik Devletleri, 15 - 19 Kasım 2024, cilt.80, (Özet Bildiri) identifier

6. Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Younossi Z., YILMAZ Y., Yu M., Isakov V., Fernández M. I. C., Wong V. W., et al.
EASL Congress 2024, Milan, İtalya, 05 Haziran 2024, cilt.80, ss.643, (Tam Metin Bildiri)

7. Transient elastography measurements of spleen stiffness are associated with treatment response to ursodeoxycholic acid in primary biliary cholangitis

ERGENÇ İ., YAPICI H., KEKLİKKIRAN Ç., YILMAZ Y.
International Liver Congress (EASL) 2023, Avusturya, 21 - 24 Haziran 2023, cilt.78, ss.389-390, (Tam Metin Bildiri)
Metrikler

Yayın

27

Yayın (WoS)

23

Yayın (Scopus)

19

Atıf (WoS)

493

H-İndeks (WoS)

9

Atıf (Scopus)

504

H-İndeks (Scopus)

8

Atıf (Scholar)

5

H-İndeks (Scholar)

1

Atıf (TrDizin)

3

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

3

Proje

2

Açık Erişim

2
BM Sürdürülebilir Kalkınma Amaçları